Vertaling van "member state " (Nederlands → Frans) :

TERMINOLOGIE

steady state | evenwicht tussen inspanning en zuurstofgebruik
équilibre cinétique | ?

IN-CONTEXT TRANSLATIONS

Compliance with the European directives on electronic submissions Compliance with the European directives requires a number of objectives to be achieved: ●● Arriving at a functional vision of communication standards with EMEA and the Member States in partnership with the industry and in line with European legislation ●● Standard project management, with important steps that are sponsored/supported by the Member States: first developing an IT infrastructure and then starting on a highly secure network followed by so-called “proofs of concept” in each field ●● Success depends above all on the FAHMP’s
Compliance with the European directives on electronic submissions Compliance with the European directives requires a number of objectives to be achieved: ●● Arriving at a functional vision of communication standards with EMEA and the Member States in partnership with the industry and in line with European legislation ●● Standard project management, with important steps that are sponsored/supported by the Member States: first developing an IT infrastructure and then starting on a highly secure network followed by so-called “proofs of concept” in each field ●● Success depends above all on the FAHMP’s

This means there is a given amount of competition between the competent medicines authorities in the various European Member States for evaluating files such as these.
This means there is a given amount of competition between the competent medicines authorities in the various European Member States for evaluating files such as these.

een sterke reductie in het aantal te evalueren dossiers waar we Concerned Member State (CMS) zijn in de wederzijdse erkenningsprocedure (MRP) en decentrale procedure (DCP);
La forte réduction du nombre de dossiers à évaluer pour lesquels nous sommes Concerned Member State (CMS) dans la procédure de reconnaissance mutuelle (MRP) et dans la procédure décentralisée (DCP) ;

België Leading Member State in de Voluntary Harmonisation Procedure (VHP – vrijwillige harmonisatieprocedure)
La Belgique, Leading Member State dans la Voluntary Harmonisation Procedure (VHP – Procédure volontaire d’harmonisation)

The reason behind this ambition is certainly not obvious: the competent medicines authorities in other Member States have the same ambition and vaccinology is, in epidemiological terms, a very broad domain, ranging from the prevention of neonatal pathology to hospital infections to sexually transmitted diseases.
The reason behind this ambition is certainly not obvious: the competent medicines authorities in other Member States have the same ambition and vaccinology is, in epidemiological terms, a very broad domain, ranging from the prevention of neonatal pathology to hospital infections to sexually transmitted diseases.

The Clinical Trial Facilitation Group (CTFG) is a collaborative effort to facilitate and harmonise clinical trials in Europe. Within the CTFG agreements have been made for various competent authorities to voluntarily arrive at a common evaluation for applications for clinical trials whenever this involves multicentre trials with participating centres from different Member States.
The Clinical Trial Facilitation Group (CTFG) is a collaborative effort to facilitate and harmonise clinical trials in Europe. Within the CTFG agreements have been made for various competent authorities to voluntarily arrive at a common evaluation for applications for clinical trials whenever this involves multicentre trials with participating centres from different Member States.

Report on the progress made in the use of biofuels and other renewable fuels in the Member States of the European Union 10/01/2007, COM (2006), 845 final.
Report on the progress made in the use of biofuels and other renewable fuels in the Member States of the European Union, 10/01/2007, COM (2006) 845 final.

U kunt in dit geval een aanvraag indienen volgens de «Post-Annex I» (bestaat enkel in het Engels) procedure (= Europese procedure). BELANGRIJKE OPMERKING: U moet binnen de zes maanden na het besluit tot opname in Bijlage 1 of 1A van de Biocidenrichtlijn van de laatste «stof-PT» combinatie de Dienst Risicobeheersing van het DG Leefmilieu inlichten omtrent uw intenties rond deze Europese procedure (toelatingsaanvraag met België als «Reference Member State» of toelatingsaanvraag in een andere EU-lidstaat met wederzijdse erkenning in België, overeenkomstig artikel 7 van het koninklijk besluit van 12 maart 2010 tot wijziging van het koninklijk besluit van 22 mei 2003 betreffende het op de markt brengen en het gebruiken van biociden).
REMARQUE IMPORTANTE : dans les six mois de la décision d'inclusion dans l'annexe 1 ou 1A de la directive sur les biocides de la dernière combinaison de substance-TP, vous devez informer le service Maîtrise des risques de la DG Environnement de vos intentions au sujet de cette procédure européenne (demande d'autorisation avec la Belgique en tant qu'État membre de référence ou demande d'autorisation dans un autre État membre de l'UE avec reconnaissance mutuelle en Belgique, conformément à l'article 7 de l'arrêté royal du 12 mars 2010 modifiant l'arrêté royal du 22 mai 2003 concernant la mise sur le marché et l'utilisation des produits biocides).

Expertenbijeenkomst: New strategies to monitor and control infections, antibiotic use an resistance in healthcare facilities in de EU member states.
Réunion d'experts : New strategies to monitor and control infections, antibiotic use and resistance in healthcare facilities in the EU member states

At European level, important texts were adopted such as Directive 2007/47/EC amending Directive 93/42/EEC concerning medical devices and Directive 90/385/EEC on the approximation of the laws of the Member States relating to active implantable medical devices, and Regulation (EC) no. 1394/2007 on advanced therapy medicinal products.
At European level, important texts were adopted such as Directive 2007/47/EC amending Directive 93/42/EEC concerning medical devices and Directive 90/385/EEC on the approximation of the laws of the Member States relating to active implantable medical devices, and Regulation (EC) no. 1394/2007 on advanced therapy medicinal products.